UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round | Business Wire

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round | Business Wire: UF Innovate | Sid Martin Biotech announces resident company Lacerta Therapeutics, a gene therapy innovator, has closed on a $30M funding round.